Phase 1
๐ Investigational Drug / Biologic
NCT05272384
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
๐ University of Alabama at Birmingham Cancer Center โ Birmingham, Alabama
View Study & Screener โ